Related by context. All words. (Click for frequent words.) 64 gastric adenocarcinoma 64 carcinomas 64 HNSCC 64 esophageal cancers 63 neoplasias 63 intestinal metaplasia 62 cell carcinomas 62 colorectal carcinoma 62 pancreatic adenocarcinoma 61 thymoma 61 papillary renal cell carcinoma 61 pT2 61 renal cell carcinomas 61 leiomyomas 61 pulmonary metastases 61 mesotheliomas 61 Anaplastic 61 subependymal giant cell 61 papillary 61 carcinoma 61 GISTs 60 invasive ductal 60 premalignant 60 cancer mCRC 60 Squamous 60 basal cell carcinoma BCC 60 endometrial hyperplasia 60 urothelial carcinoma 60 pituitary adenomas 60 neoplasm 60 neoplastic lesions 60 bladder cancers 60 squamous cell cancers 60 Adenomas 60 prostate carcinoma 60 malignant neoplasm 60 KRAS mutations occur 59 recurrent squamous cell carcinoma 59 lung adenocarcinomas 59 squamous cell carcinomas 59 Actinic Keratosis 59 hyperplastic 59 cholelithiasis 59 gastric cancers 59 bladder tumors 59 cell carcinoma 59 papillary carcinoma 59 fallopian tube carcinoma 59 basal cell carcinomas 59 adenomatous 59 metastatic malignant 59 transitional cell carcinoma 59 breast carcinoma 59 pheochromocytoma 59 endometrial cancers 59 nasopharyngeal carcinoma 59 carcinoid tumor 59 colorectal neoplasms 59 malignant neoplasms 58 choriocarcinoma 58 pancreatic cancers 58 uveal melanoma 58 underwent surgical resection 58 metastatic gastric 58 PAOD 58 nodal metastasis 58 precancerous cervical 58 gastrointestinal cancers 58 metachronous 58 carcinoid tumors 58 vaginal lesions 58 nonmelanoma skin cancers 58 malignant lymphomas 58 breast carcinomas 58 Papillary 58 distant metastasis 58 metastatic colorectal 58 squamous cell cancer 58 HGPIN 58 Squamous Cell Carcinoma 58 NMIBC 58 transplantation HSCT 58 Glioblastoma Multiforme 58 colorectal cancer CRC 58 malignant lymphoma 58 leiomyosarcoma 58 squamous cell carcinoma SCC 58 seminoma 58 leukoplakia 58 Malignant Melanoma 58 intraepithelial neoplasia 58 neoplasia 58 granulomatous 58 lung carcinomas 58 adenocarcinomas 58 esophagogastric junction 58 Carcinoma 58 precursor lesions 58 paragangliomas 58 prostate adenocarcinoma 58 prostate cancer CaP 57 SCCHN 57 neuroendocrine cancers 57 ductal carcinomas 57 cutaneous melanoma 57 invasive aspergillosis 57 meningiomas 57 undergone radical prostatectomy 57 fibroma 57 node metastasis 57 pharyngeal cancer 57 ertapenem 57 colorectal polyp 57 adenoma 57 epithelial tumors 57 invasive candidiasis 57 uterine tumors 57 FluCAM arm 57 Hurthle cell 57 gastrointestinal perforation 57 nonmetastatic 57 nonsmall cell lung cancer 57 neoplasms 57 histologic subtype 57 colorectal adenoma 57 advanced adenomas 57 CIN2 57 atypical ductal hyperplasia 57 skeletal metastases 57 oesophageal squamous cell carcinoma 57 Neoplasms 57 metastatic lesions 57 pancreatic gastric 57 diverticular bleeding 57 urothelial cancer 57 invasive carcinomas 57 SSc 57 pancreatic neuroendocrine 57 underwent radical prostatectomy 57 MGUS 57 Legg Calvé Perthes disease 57 cervical lymph nodes 57 lobular 57 paraganglioma 57 recurrent glioblastoma multiforme 57 Endometrial 57 bullous 57 NSCLC tumors 57 ductal adenocarcinoma 57 gastric carcinoma 57 symptomatic BPH 57 surgically resected 57 proximal colon 57 peritoneal cancer 57 lymphoma subtypes 56 situ LCIS 56 malignancies 56 underwent resection 56 pleomorphic 56 liver metastases 56 neuroblastoma tumors 56 histological subtype 56 B Cell Lymphoma 56 thromboembolic events 56 gastrointestinal stromal tumor 56 CIN2 + 56 mucinous 56 grade cervical intraepithelial 56 pancreatic carcinoma 56 occlusive disease 56 carcinoid 56 intestinal polyps 56 esophageal squamous cell carcinoma 56 explants 56 histologically 56 leukemia AML 56 PNET 56 gastroesophageal junction 56 Leukemias 56 Carcinomas 56 chemoradiotherapy 56 Proxinium TM 56 basal cell skin 56 precancerous lesion 56 polyposis 56 resectable 56 liver resection 56 squamous cell lung cancer 56 malignant pleural mesothelioma 56 necrotizing 56 lipomas 56 cystic lesions 56 ovarian breast 56 papillomas 56 transplantation HCT 56 thyroid nodules 56 nasopharyngeal cancer 56 tumors GIST 56 colorectal tumors 56 hepatocellular carcinoma HCC 56 precancerous cervical lesions 56 anaplastic 56 dysplastic lesions 56 MALT lymphoma 56 ovarian carcinoma 56 ovarian lung 56 metastatic neuroendocrine tumors 56 lobular breast cancer 56 cholangiocarcinoma 56 histopathologic examination 55 malignant growths 55 atrophic gastritis 55 squamous carcinoma 55 osteosarcomas 55 advanced adenoma 55 external genital lesions 55 thyroid carcinoma 55 prostate cancer CRPC 55 sarcomas 55 primary hyperparathyroidism 55 gastrointestinal stromal tumors GIST 55 superficial bladder cancer 55 squamous cell 55 situ CIS 55 acute myeloid 55 ADPKD 55 EGFR mutation 55 colorectal adenocarcinoma 55 Glioblastoma Multiforme GBM 55 esophageal gastric 55 familial amyloidotic polyneuropathy FAP 55 squamous cell carcinoma 55 immunohistochemical staining 55 Trichomonas vaginalis 55 immunocompetent 55 tumor xenograft models 55 leukoencephalopathy 55 abacavir Ziagen 55 ocular disorders 55 epithelial ovarian 55 lymph node metastasis 55 squamous 55 unresectable tumors 55 allogeneic HSCT 55 Trichophyton rubrum 55 monoclonal gammopathy 55 cytoreduction 55 Candida infection 55 Non Alcoholic Fatty 55 PCa 55 varices 55 premalignant lesions 55 desmoplastic 55 malignant fibrous histiocytoma 55 tumoral 55 differentiated thyroid 55 chemoresistant 55 nonproliferative 55 metaplasia 55 pancreatic prostate 55 metastatic GIST 55 genes differentially expressed 55 gastrectomy 55 osteoid osteoma 55 pilocytic astrocytomas 55 prostate carcinomas 55 hepatocellular cancer 55 idiopathic myelofibrosis 55 adenomatous polyps 55 hepatic metastases 55 sentinel lymph nodes 55 bone metastasis 55 recurrent metastatic 55 CTEPH 55 pT3 55 invasive ductal carcinoma 55 renal tumors 55 cisplatin resistant 55 rectal cancers 55 nodular lesions 55 lymphocytosis 55 Entamoeba histolytica 55 ovarian pancreatic 55 astrocytomas 55 hamartomas 55 follicular thyroid cancer 55 bronchoalveolar 55 breast pancreatic 55 astrocytoma 55 treat benign prostatic 55 GBM tumors 55 epithelioid 55 Surgical resection 55 prostate TURP 55 malignant ascites 55 oral squamous cell 55 anaplastic lymphoma kinase ALK 55 leukemia ALL 55 neuroendocrine carcinoma 54 Hematologic 54 urolithiasis 54 recurrent venous thromboembolism 54 testicular cancers 54 allogeneic bone marrow 54 ASCUS 54 Malignancies 54 pancreatic bladder 54 HER2 overexpression 54 transurethral resection 54 endometrioid 54 chronic GVHD 54 radical prostatectomy RP 54 oropharyngeal squamous cell carcinoma 54 Chronic lymphocytic leukemia 54 axillary lymph nodes 54 Immunohistochemical staining 54 flutamide 54 cytologically confirmed 54 candidemia 54 adrenalectomy 54 interstitial fibrosis 54 oropharyngeal cancer 54 hypervascular tumors 54 anal cancers 54 metastatic adenocarcinoma 54 pancreatic lung 54 benign nodules 54 neoplastic cells 54 liposarcoma 54 acute aortic dissection 54 histological subtypes 54 myeloproliferative disorders 54 gastrointestinal stromal tumors 54 myeloproliferative disorder 54 essential thrombocythemia 54 cytoreductive surgery 54 endometrial carcinoma 54 thalidomide Thalomid 54 nonmelanoma skin cancer 54 melanocytic nevi 54 Li Fraumeni Syndrome 54 radioiodine therapy 54 Mitomycin C 54 cell lymphoma ALCL 54 lymph node metastases 54 Medullary thyroid cancer 54 autoimmune hemolytic anemia 54 papilloma 54 invasive lobular 54 urethral stricture 54 Stomatitis 54 leiomyoma 54 neoplastic 54 LVNC 54 cell lymphoma CTCL 54 total thyroidectomy 54 Toxicities 54 hypertrophic scarring 54 octreotide LAR 54 cerebral vasospasm 54 neuroendocrine tumors 54 etiologic agent 54 metastatic lymph nodes 54 underwent prostatectomy 54 acute leukemias 54 synovial sarcoma 54 Cell Carcinoma 54 Gorlin syndrome 54 polypoid 54 xenograft tumors 54 HCV infections 54 epithelial ovarian cancer 54 lobular carcinoma 54 metastatic pancreatic 54 hepatorenal syndrome 54 HER2 amplification 54 mycophenolate mofetil 54 neurological manifestations 54 renal cell carcinoma 54 hepatoma 54 ANCA associated 54 lymphocytic 54 calculi 54 hypervascular 54 hepatocellular carcinomas 54 gastric cardia 54 BCG refractory 54 lymphadenectomy 54 testicular tumors 54 lymphoid tumors 54 colorectal liver 54 nodular melanoma 54 neoadjuvant therapy 54 lung cancers 53 oesophageal 53 Prostatic 53 hamartoma 53 eccrine 53 sCJD 53 EUS FNA 53 lymphadenopathy 53 myeloproliferative neoplasms 53 keloid scarring 53 intravesical therapy 53 metastatic HER2 positive 53 vestibular schwannomas 53 onset diabetes mellitus 53 lobular cancer 53 lichen planus 53 intracerebral 53 prostate cancer PCa 53 lymphatic tissue 53 polycythemia vera PV 53 parathyroidectomy 53 micrometastases 53 breast cancer recurrences 53 neurofibromas 53 carotid stenosis 53 medulloblastomas 53 metastatic carcinoma 53 Idiopathic Pulmonary Fibrosis 53 pheochromocytomas 53 distant metastases 53 metastatic malignant melanoma 53 recurrent malignant glioma 53 esophageal tumors 53 colon tumors 53 testicular germ cell 53 malignant polyps 53 pericardial effusion 53 ductal cancer 53 Cholangiocarcinoma 53 chlamydial 53 small lymphocytic lymphoma 53 Adenocarcinoma 53 lymphoid malignancies 53 IgG antibodies 53 Aneurysm Repair 53 gallstone disease 53 cervical lymph node 53 transthyretin amyloidosis 53 Renal Cell Carcinoma RCC 53 basal cell 53 seminomas 53 vulvar intraepithelial neoplasia 53 ependymoma 53 clinically localized prostate 53 parathyroid carcinoma 53 mycosis fungoides 53 Epidermal Growth Factor Receptor 53 bronchogenic carcinoma 53 sulfadiazine 53 benign polyps 53 ALND 53 pediatric acute lymphoblastic 53 pancreatic ovarian 53 locoregional 53 metastases 53 CLL SLL 53 severe oral mucositis 53 pCR 53 pre cancerous growths 53 advanced epithelial ovarian 53 GSTP1 53 GnRH agonists 53 Diffuse Large B 53 reflux esophagitis 53 Myelodysplastic syndromes MDS 53 metastatic ovarian cancer 53 myxoid 53 EGFR expressing 53 invasive fungal infection 53 arteriovenous malformations 53 tumor histology 53 Dysplasia 53 fallopian tube cancers 53 trans retinoic acid 53 histological diagnosis 53 CYT# potent vascular disrupting 53 renal carcinoma 53 glioblastoma multiforme GBM 53 chromophobe 53 lung esophageal 53 Histological examination 53 EGFR mutations 53 liver metastasis 53 LHRH receptor positive 53 lung adenocarcinoma 53 lung nodules 53 hepatocellular carcinoma 53 colorectal polyps 53 prostate cancer metastases 53 ATTR PN 53 pancreatic ductal adenocarcinoma 53 molecular subtypes 53 syngeneic 53 lung metastasis 53 monocytic 53 pseudotumor 53 Ductal carcinoma 53 Glioma 53 idiopathic PAH 53 receptor tyrosine kinase inhibitor 53 bladder ovarian 53 penile cancers 53 relapsed MM 53 myelofibrosis polycythemia vera 53 essential thrombocythemia ET 53 atypical hyperplasia 53 Candida infections 53 lung pancreatic 53 osteolytic 53 metastatic lung cancer 53 invasive carcinoma 53 gastroduodenal 53 histologic 53 docetaxel Taxotere ® 53 lymphocytic leukemia 53 HER2 positive cancers 53 familial adenomatous polyposis 53 urothelial bladder cancer 53 mCRC patients 53 aortic atherosclerosis 53 intraductal 53 esophageal carcinoma 53 advanced neoplasia 53 Amrubicin 53 biliary tract cancers 53 Immunohistochemical analysis 53 stage IIIb IV 53 Epstein Barr virus EBV 53 pancreatic colon 53 thymectomy 53 ductal breast cancer 53 operable breast cancer 53 benign neoplasms 53 orchiectomy 53 pulmonary alveolar 53 Invasive Breast Cancer 53 gemcitabine carboplatin 53 laryngeal cancer 53 stage IIIB 53 GNAQ 53 cervical vaginal 53 bronchoalveolar lavage BAL 53 lung metastases 53 lymphomas 53 urothelial 53 kidney urologic 53 histologically confirmed 53 pulmonary metastasis 53 N. gonorrhoeae 53 atherosclerotic lesions 53 bronchoalveolar lavage 53 serological markers 53 Sjögren syndrome 53 colorectal adenomas 53 Benign prostatic hyperplasia BPH 53 cytogenetic abnormalities 53 Acute myeloid leukemia 53 splenic 53 Corynebacterium 53 infliximab etanercept 53 medullary thyroid cancer 53 cetuximab Erbitux 53 chronic periodontitis 53 intra abdominal abscess 53 Vulvar 52 rebleeding 52 malignant brain 52 cervical lesions 52 Vicinium TM 52 cynomolgus monkeys 52 lung tumors 52 gastrointestinal stromal tumors GISTs 52 prostate cancers 52 hormone refractory metastatic prostate 52 chondrosarcoma 52 occlusion CRVO 52 oesophageal adenocarcinoma 52 motor neuron degeneration 52 bowel cancers 52 carbapenem resistant 52 CP CPPS 52 serous ovarian cancer 52 BRCA1 mutations 52 supratentorial 52 recurrent glioblastoma multiforme GBM 52 glioma tumors 52 S aureus 52 bacteriuria 52 Metastatic 52 Prostatitis 52 ErbB2 positive 52 Buerger Disease 52 Barrett esophagus BE 52 castrate resistant 52 malignant lesions 52 Crohn disease CD 52 C. trachomatis 52 Androgenetic Alopecia 52 gastrointestinal stromal tumor GIST 52 grade dysplasia 52 mucosal lesions 52 soft tissue sarcomas 52 hypereosinophilic syndrome 52 locoregional recurrence 52 localized renal 52 hypermethylated 52 grade gliomas 52 malignant pancreatic 52 Astrocytoma 52 IDH1 mutation 52 genital herpes infections 52 precancers 52 micafungin 52 Synovial 52 BCR ABL mutations 52 HBeAg negative 52 intracranial tumors 52 normal karyotype 52 sarcoma 52 SUVmax 52 malignant tumors 52 radical nephrectomy 52 tonsillar 52 coagulation disorders 52 Enterobacter cloacae 52 androgenetic alopecia 52 telomerase inhibition 52 Gliomas 52 non squamous NSCLC 52 Cell Lymphoma 52 pleurodesis 52 Asymptomatic 52 variceal hemorrhage 52 recurrent NSCLC 52 cervical intraepithelial neoplasia 52 osteopetrosis 52 thyroid cancers 52 candidiasis 52 genitourinary cancers 52 infantile hemangiomas 52 tumor nodules 52 mammary tumors 52 CMV disease 52 BRCA deficient 52 Myelodysplastic Syndrome MDS 52 Kaposi sarcoma 52 neurologic complications 52 malignancy 52 Cutaneous T 52 CMV infections 52 gonococcal 52 Chronic Lymphocytic Leukemia CLL 52 Histologic 52 Gleevec resistant 52 Sezary syndrome 52 cortical dysplasia 52 orthotopic 52 dermatophytes 52 sorafenib Nexavar 52 ductal 52 colorectal liver metastases 52 gonococcal infection 52 immunohistochemical 52 intravenous bisphosphonates 52 metastatic bladder 52 lavage fluid 52 nephrogenic 52 thymic carcinoma 52 Helicobacter pylori infection 52 specific antigen PSA 52 colorectal lung 52 hematological diseases 52 PCNSL 52 taxane resistant 52 mcL 52 noncancerous tumor 52 Hemorrhagic 52 grade squamous intraepithelial 52 adrenocortical cancer 52 S. mansoni 52 prostate cancer mCRPC 52 N. Engl 52 pancreatic fistula 52 BRCA mutation carriers 52 esophageal adenocarcinoma 52 chronic myeloid 52 gynecologic malignancy 52 cytogenetic responses 52 pre cancerous lesion 52 Lymphomas 52 histologic subtypes 52 myelomas 52 lesions 52 familial ALS 52 antitumor effect 52 basal cell nevus syndrome 52 CIN3 52 systemic fungal infections 52 adenocarcinoma 52 Acute Myelogenous Leukemia 52 hepatocellular 52 systemic amyloidosis 52 KRAS mutation 52 vivax 52 bile duct cancers 52 SSc patients 52 Gastric cancer 52 serum prostate 52 IV NSCLC 52 gynecological malignancies 52 non squamous 52 contralateral breast 52 pegylated liposomal doxorubicin 52 epithelial cancers 52 urinary bladder cancer 52 sinonasal 52 coronary blockages 52 ara C 52 osteosarcoma Ewing sarcoma 52 uterine cancers 52 KRAS wild 52 biochemical recurrence 52 aplasia 52 Li Fraumeni 52 colorectal carcinomas 52 Neisseria 52 Adenoma 52 eosinophilic 52 extrahepatic 52 hepatic liver 52 P. gingivalis 52 ipsilateral breast 52 diabetes mellitus DM 52 cancerdefine 52 chemoembolization 52 Uterine fibroids 52 schwannomas 52 cancers 52 Hodgkin lymphoma HL 52 Polymorphisms 52 basal cell cancers 52 Systemic Lupus Erythematosus SLE 52 thromboses 51 lung lesions 51 submandibular gland 51 metastatic renal cell carcinoma 51 inhibits protein synthesis 51 colon carcinoma 51 GSTT1 51 mesenteric 51 thyroid carcinomas 51 pancreatic islet cell 51 Chronic Myelogenous Leukemia CML 51 uterine cervix 51 sarcomatoid 51 portal vein thrombosis 51 leukemic blasts 51 adenomas 51 hepatic fibrosis 51 huN# DM1 51 prostate pancreatic 51 Sclerosing 51 vasculopathy 51 cervical carcinoma 51 grade glioma 51 colorectal gastric 51 pancytopenia 51 gastric cancer 51 posaconazole 51 node metastases 51 Fluorouracil 51 eflornithine 51 Enzastaurin 51 pan HDAC inhibitor 51 anaplastic astrocytoma 51 hepatobiliary 51 fluconazole resistant 51 Synovial sarcoma 51 jejunal 51 autosomal dominant polycystic kidney 51 thrombocytopenic 51 primitive neuroectodermal tumor 51 Refractory Hodgkin Lymphoma 51 experimentally induced 51 mRCC 51 extracranial 51 T1a 51 venous malformations 51 esophagogastric 51 Veno Occlusive Disease 51 metastatic melanomas 51 Adjuvant chemotherapy 51 HER2 amplified 51 endothelial activation 51 cancerous enlargement 51 Epithelial ovarian cancer 51 Folfox 51 pancreatic neuroendocrine tumors 51 gefitinib Iressa 51 HNPCC 51 angiosarcoma 51 Ischemic 51 tumors 51 SLNB 51 acute GvHD 51 cystectomy 51 acid phosphatase PAP 51 prostate cancer HRPC 51 osteochondromas 51 pilocytic astrocytoma 51 Squamous cell carcinomas 51 pancreatic 51 hematologic toxicity 51 recurrent laryngeal nerve 51 chronic prostatitis 51 medullary thyroid 51 osteoid 51 Basal cell 51 ocular toxicity 51 respiratory syndrome virus 51 colorectal breast 51 jejunum 51 metastatic tumors 51 Leydig cell 51 Hepatocellular Carcinoma HCC 51 bronchioloalveolar carcinoma 51 colorectal ovarian 51 Tumours 51 lobular carcinomas 51 alpha1 antitrypsin deficiency 51 pulmonary fungal infections 51 castrate resistant prostate cancer 51 prostate ovarian 51 ADAMTS# 51 GIST tumors 51 ductal lobular 51 submucosa 51 colorectum 51 neoplasia CIN 51 pertuzumab 51 histologically proven 51 malignant melanomas 51 common hematologic malignancy 51 tumor recurrence 51 Squamous Cell 51 ansamycin 51 adenoid cystic carcinoma 51 ALK mutations 51 promoter methylation 51 Soft Tissue Sarcoma 51 ovarian cervical 51 metastatic prostate cancer 51 intraoperative complications 51 carcinoma HCC 51 clinicopathologic 51 haematologic malignancies 51 dysplastic 51 ovarian tumors 51 pancreatectomy 51 complement inhibitor eculizumab 51 teratoma 51 bevacizumab Avastin ® 51 thromboembolism 51 radiographic findings 51 inducible nitric oxide synthase 51 ATTR CM 51 FVIII inhibitors 51 ruptured brain aneurysms 51 CIN3 + 51 KRAS mutations 51 mutated KRAS 51 Basal Cell 51 brivanib 51 Ozarelix 51 hydronephrosis 51 Systemic Sclerosis 51 leukemia CLL 51 indolent tumors 51 Metastatic Colorectal Cancer 51 Hepatic 51 ascites 51 ocular melanoma 51 HPV# 51 HER2 expression 51 carotid plaques 51 radiolabeled TM# 51 KRAS oncogene 51 pituitary adenoma 51 endocrine tumors 51 tumor necrosis 51 NSCLC 51 clinically detectable 51 Multiple Myeloma MM 51 Sydenham chorea 51 abnormal angiogenesis 51 Bronchiectasis 51 monogenic 51 Small Intestine 51 sporadic ALS 51 myoma 51 Osteosarcoma 51 carcinomatosis 51 enterococcal 51 Non Alcoholic Steatohepatitis 51 metastatic basal cell 51 generalized seizures 51 CALGB # [002] 51 cranial irradiation 51 Wegener granulomatosis 51 haematuria 51 Atypical Hemolytic Uremic Syndrome 51 IgA deficiency 51 carcinoid cancer 51 invasive fungal infections 51 haematological malignancies 51 rs# [001] 51 vulvar cancer 51 visceral metastases 51 fosbretabulin 51 MYCN amplification 51 pancreatic tumor 51 LHON 51 micronuclei 51 laryngeal cancers 51 proliferative disorders 51 herpesviruses 51 biliary tree 51 pelvic irradiation 51 Brain metastases 51 T1c 51 Thrombocytopenia 51 invasive cervical cancer 51 diffuse gastric 51 infective endocarditis 51 metastatic breast 51 benign proliferative breast 51 Meningiomas 51 multikinase inhibitor 51 histologies 51 tuberous sclerosis TS 51 Heavy menstrual bleeding 51 FGFR2 51 infection progressive multifocal 51 osteochondroma 51 molecule epidermal 51 3 carbinol 51 diffuse intrinsic pontine glioma 51 curative resection 51 ABCB1 51 biopsy specimen 51 T#I mutant 51 polycystic kidneys 51 lung colorectal 51 viral titers 51 aromatase enzyme 51 DBMD 51 meningioma 51 heavily pretreated 51 completely resected 51 Cytotoxic T 51 CC genotype 51 metastatic androgen independent 51 zalutumumab 51 finasteride Proscar 50 colorectal cancers 50 cervical neoplasia 50 mitochondrial toxicity 50 orchitis 50 acute promyelocytic leukemia APL 50 aerodigestive tract 50 solar keratosis 50 Brentuximab Vedotin SGN 50 H pylori 50 pneumococci 50 hematopoietic cancers 50 herpes zoster shingles 50 fluoroquinolone resistant 50 T1DM 50 axillary lymph node dissection 50 p# mutations 50 melanoma tumors 50 locoregional disease 50 preclinical xenograft models 50 chronic HBV infection 50 cystic fibrosis chronic pancreatitis 50 radiochemotherapy 50 hyperacute 50 mutated KRAS gene 50 Upregulation 50 mutated K ras 50 Group RTOG 50 ovarian carcinomas 50 transthyretin 50 glomerulonephritis 50 Aeromonas 50 corneal epithelial